CIRM Funded Clinical Trials
Clinical Development of ETX101, a Gene Regulation Therapy for SCN1A+ Dravet Syndrome
Disease Area:
Epilepsy, Genetic Disorder
Trial Sponsor:
Encoded Therapeutics
Trial Stage:
Phase 2
Trial Status:
Launching
Targeted Enrollment:
N/A